SONOMA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $2.98 per share for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-16.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-06-16
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-06-30 was $2.32.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2016-12-31 was $4.18, a 12.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2016-09-30 was $3.64, a 14.35% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2016-06-30 was $3.46, a 37.09% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2026 was $2.98, a 33.63% increase from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $2.23, a 1386.67% increase from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $0.15, a 83.70% decline from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $0.92, a 77.17% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $2.98 10-K · filed 2026-06-16 | |||||||
| 2025-12-31 | $2.32 10-Q · filed 2026-02-10 | |||||||
| 2025-09-30 | $2.32 10-Q · filed 2025-11-04 | |||||||
| 2025-06-30 | $2.32 10-Q · filed 2025-08-07 | |||||||
| 2025-03-31 | $2.23 10-K · filed 2026-06-16 | |||||||
| 2024-03-31 | $0.15 10-K · filed 2025-06-17 | |||||||
| 2023-03-31 | $0.92 10-K · filed 2024-06-17 | |||||||
| 2022-03-31 | $4.03 10-K · filed 2023-06-21 | |||||||
| 2021-03-31 | $5.48 10-K · filed 2022-07-13 | |||||||
| 2020-03-31 | $3.69 10-K · filed 2021-07-14 | |||||||
| 2019-03-31 | $9.00 10-K · filed 2020-07-10 | |||||||
| 2018-03-31 | $53.73 10-K · filed 2019-07-01 | $5.97 10-K · filed 2018-06-26 | ||||||
| 2017-03-31 | $4.12 10-K · filed 2018-06-26 | |||||||
| 2016-12-31 | $4.18 10-Q · filed 2017-02-17 | $4.08 10-Q · filed 2017-02-17 | ||||||
| 2016-09-30 | $3.64 10-Q · filed 2016-11-15 | $3.68 10-Q · filed 2016-11-15 | ||||||
| 2016-06-30 | $3.46 10-Q · filed 2016-08-09 | |||||||
| 2016-03-31 | $4.45 10-K · filed 2017-06-28 | |||||||
| 2015-12-31 | $4.75 10-Q · filed 2017-02-17 | $0.95 10-Q · filed 2016-02-16 | $4.40 10-Q · filed 2017-02-17 | $0.88 10-Q · filed 2016-02-16 | ||||
| 2015-09-30 | $4.25 10-Q · filed 2016-11-15 | $0.85 10-Q · filed 2015-11-10 | $4.40 10-Q · filed 2016-11-15 | $0.88 10-Q · filed 2015-11-10 | ||||
| 2015-06-30 | $5.50 10-Q · filed 2016-08-09 | $1.08 10-Q · filed 2015-08-07 | ||||||
| 2014-12-31 | $1.32 10-Q · filed 2016-02-16 | $2.21 10-Q · filed 2016-02-16 | ||||||
| 2014-09-30 | $2.39 10-Q · filed 2015-11-10 | $2.10 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |